Hormone independence of EF1α-PyMT-ZsGreen-transduced MEC tumors. a Half-maximal inhibitory concentration values of wild-type MECs and cells isolated from luminal CD133+, luminal CD133−, basal, and stem cell tumors treated for 48 h with 4-hydroxytamoxifen (4-OHT). No significant differences among the viability of tumor cells and normal MECs were observed after 4-OHT treatment (t test). b Assessment of tumor growth response to ovariectomy. Transduced primary cells were transplanted into ovariectomized mice to test if lack of hormone signaling would result in reduced tumor growth from luminal CD133+ cells. No differences in tumor latencies were observed among tumor groups (n = number of mice). (TIFF 1112 kb
Showing proliferation characteristics of mammary tumors from K14Crep53 F/F and K14CreERβ F/F 53 F/F ...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
a Comparison of individual tumor growth plots for 468-shCDH1-B and 468-shCDH1-D tumors to day of tum...
Percentage of tumors with a dominant histology. Each tumor was classified based on the histological ...
PyMT expression and activity in tumors. a RT-qPCR quantification of relative PyMT mRNA expression le...
Distribution of basal and luminal subtypes. Distribution of basal and luminal tumor subtypes generat...
Postinfection PyMT expression in cultured total MECs. a Flow cytometric analysis of percentage of Zs...
Figure S2. p18-/-;Brca1MGKO and p16-/-;Brca1MGKO tumor cells generate reproducible ER-negative Brca1...
Top 100 unique differentially expressed genes in the luminal CD133â tumor cluster compared with th...
PyMT activity comparison with tumor histology, molecular subtype, and metastasis. a Western blot qua...
Quantification of the number of metastases per tumor histology. A histology was assigned to a tumor ...
Figure S3. Estrogen promotes Brca1-proficient and deficient mammary tumor initiation (A)Â Western bl...
Figure S2. Expression of MSC stem-like markers CD44, CD73, and CD105 was analyzed by RT-PCR in three...
Enriched MEC populations metastasize to lung. Representative fluorescence images of lungs from mice ...
Unsupervised hierarchical clustering of tumors generated from enriched MEC populations. Tumor cell o...
Showing proliferation characteristics of mammary tumors from K14Crep53 F/F and K14CreERβ F/F 53 F/F ...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
a Comparison of individual tumor growth plots for 468-shCDH1-B and 468-shCDH1-D tumors to day of tum...
Percentage of tumors with a dominant histology. Each tumor was classified based on the histological ...
PyMT expression and activity in tumors. a RT-qPCR quantification of relative PyMT mRNA expression le...
Distribution of basal and luminal subtypes. Distribution of basal and luminal tumor subtypes generat...
Postinfection PyMT expression in cultured total MECs. a Flow cytometric analysis of percentage of Zs...
Figure S2. p18-/-;Brca1MGKO and p16-/-;Brca1MGKO tumor cells generate reproducible ER-negative Brca1...
Top 100 unique differentially expressed genes in the luminal CD133â tumor cluster compared with th...
PyMT activity comparison with tumor histology, molecular subtype, and metastasis. a Western blot qua...
Quantification of the number of metastases per tumor histology. A histology was assigned to a tumor ...
Figure S3. Estrogen promotes Brca1-proficient and deficient mammary tumor initiation (A)Â Western bl...
Figure S2. Expression of MSC stem-like markers CD44, CD73, and CD105 was analyzed by RT-PCR in three...
Enriched MEC populations metastasize to lung. Representative fluorescence images of lungs from mice ...
Unsupervised hierarchical clustering of tumors generated from enriched MEC populations. Tumor cell o...
Showing proliferation characteristics of mammary tumors from K14Crep53 F/F and K14CreERβ F/F 53 F/F ...
Figure S1. Expression of CSC-associated genes up-regulated in AB12 and RN5 cells after cisplatin tre...
a Comparison of individual tumor growth plots for 468-shCDH1-B and 468-shCDH1-D tumors to day of tum...